疏肝益脑针刺法联合佐米曲普坦治疗肝阳上亢证偏头痛的效果

doi:10.3760/cma.j.cn441417-20241129-13022

国际医药卫生导报 ›› 2025, Vol. 31 ›› Issue (13): 2221-2225.DOI: 10.3760/cma.j.cn441417-20241129-13022

疏肝益脑针刺法联合佐米曲普坦治疗肝阳上亢证偏头痛的效果

王斌¹ 张艳²

¹陕西中医药大学附属医院针灸推拿科，咸阳 712000；²咸阳市中心医院神经内科，咸阳 712000

收稿日期:2024-11-29 出版日期:2025-07-01 发布日期:2025-08-04
通讯作者: 张艳，Email：290272608@qq.com
基金资助:
陕西省重点研发计划（2021SF-404）；咸阳市科技成果推广计划（2019KT-10）

The effect of liver-sparing and brain-benefiting acupuncture method combined with zolmitriptan in the treatment of migraine with hyperactivity of liver-yang syndrome

Wang Bin¹, Zhang Yan²

¹Department of Acupuncture and Massage, Affiliated Hospital of Shaanxi University of Chinese Medicine, Xianyang 712000, China; ²Department of Neurology, Xianyang Central Hospital, Xianyang 712000, China

Received:2024-11-29 Online:2025-07-01 Published:2025-08-04
Contact: Zhang Yan, Email:290272608@qq.com
Supported by:
Shaanxi Province Key Research and Development Program (2021SF-404); Xianyang City Science and Technology Achievement Promotion Program (2019KT-10)

摘要/Abstract

摘要：

目的　观察疏肝益脑针刺法联合佐米曲普坦治疗肝阳上亢证偏头痛的效果。方法　选取2021年5月至2022年10月陕西中医药大学附属医院收治的90例肝阳上亢证偏头痛患者作为研究对象。采用信封法，将患者分为对照组（45例）和针刺组（45例）。对照组男19例，女26例；年龄19～74（49.63±7.84）岁；病程1～32（6.85±1.45）年。针刺组男16例，女29例；年龄20～75（48.78±8.02）岁；病程1～29（6.79±1.50）年。对照组采用佐米曲普坦治疗，针刺组在对照组基础上联合疏肝益脑针刺法治疗。两组均连续治疗2周。比较两组治疗前和治疗后1 h、2 h、4 h疼痛程度［视觉模拟评分（VAS）］，治疗前后血管活性物质水平［降钙素基因相关肽（CGRP）、内皮素-1（ET-1）、β-内咖肽（β-EP）、5-羟色胺（5-HT）］、炎症反应相关酶水平［环氧合酶-2（COX-2）、一氧化氮合酶（iNOS）］、偏头痛症状积分（头痛严重程度、伴随症状、每月发作次数及每次持续时间）、中医证候评分（头胀痛、易怒烦躁、少寐多梦、耳鸣眩晕、面红目赤、口苦咽干），治疗期间不良反应发生情况。采用独立样本t检验、配对t检验和χ²检验进行统计学分析。结果　治疗后1 h、2 h、4 h，针刺组VAS评分均低于对照组［（3.28±0.70）分比（4.02±1.14）分、（2.67±0.68）分比（3.20±0.54）分、（1.87±0.42）分比（2.34±0.51）分］（均P<0.05）。治疗后，针刺组CGRP、ET-1水平均低于对照组［（10.14±1.44）ng/L比（13.36±1.87）ng/L、（56.74±5.51）ng/L比（65.86±5.87）ng/L］，β-EP、5-HT水平均高于对照组［（83.45±9.61）ng/L比（71.63±8.47）ng/L、（298.86±30.48）ng/L比（272.36±28.94）ng/L］（均P<0.05）；针刺组COX-2、iNOS水平均低于对照组［（1.84±0.51）μg/L比（2.21±0.63）μg/L、（1.35±0.48）μg/L比（3.08±0.77）μg/L］（均P<0.05）；针刺组头痛严重程度、伴随症状、每月发作次数及每次持续时间积分均低于对照组（均P<0.05）；针刺组头胀痛、易怒烦躁、少寐多梦、耳鸣眩晕、面红目赤、口苦咽干评分均低于对照组（均P<0.05）。治疗期间，两组均未发生不良反应。结论　疏肝益脑针刺法联合佐米曲普坦治疗肝阳上亢证偏头痛患者的效果较好，可缓解疼痛，减轻偏头痛症状，调节血管活性物质、炎症反应相关酶水平。

关键词: 偏头痛, 疏肝益脑针刺法, 佐米曲普坦, 急性发作, 血管活性物质, 炎症反应相关酶

Abstract:

Objective　To observe the effect of liver-sparing and brain-benefiting acupuncture method combined with zolmitriptan in the treatment of migraine with hyperactivity of liver-yang syndrome. Methods　A total of 90 patients with migraine with hyperactivity of liver-yang syndrome who were admitted to Affiliated Hospital of Shaanxi University of Chinese Medicine from May 2021 to October 2022 were selected as the study subjects. Using the envelope method, the patients were divided into the control group (45 cases) and the acupuncture group (45 cases). There were 19 males and 26 females in the control group, aged 19-74 (49.63±7.84) years, course of the disease 1-32 (6.85±1.45) years. There were 16 males and 29 females in the acupuncture group, aged 20-75 (48.78±8.02) years, course of the disease 1-29 (6.79±1.50) years. The control group was treated with zolmitriptan, while the acupuncture group was treated in addition to the control group with liver-sparing and brain-benefiting acupuncture method. Both groups were treated continuously for 2 weeks. Compare the pain levels [visual analogue scale (VAS)] before and after treatment in the two groups at 1 h, 2 h, and 4 h; the levels of vaso-active substance [calcitonin gene-related peptide (CGRP), endothelin-1 (ET-1), β-epinephrine (β-EP), 5-hydroxytryptamine (5-HT)], the levels of inflammatory response-related enzymes [cyclooxygenase-2 (COX-2), nitric oxide synthase (iNOS)], the migraine symptom scores (headache severity, accompanying symptoms, monthly attack frequency and duration per attack), the traditional Chinese medicine syndrome scores (headache and dizziness, irritability and restlessness, insomnia and frequent dreams, tinnitus and vertigo, facial flushing and redness, bitter mouth and dry throat) before and after treatment; and the occurrence of adverse reactions during treatment. Independent sample t test, paired t test, and χ² test were used for statistical analysis. Results　At 1 h, 2 h, and 4 h after treatment, the VAS scores of the acupuncture group were all lower than those of the control group [(3.28±0.70) points vs. (4.02±1.14) points, (2.67±0.68) points vs. (3.20±0.54) points, (1.87±0.42) points vs. (2.34±0.51) points] (all P<0.05). After treatment, the levels of CGRP and ET-1 in the acupuncture group were lower than those in the control group [(10.14±1.44) ng/L vs. (13.36±1.87) ng/L, (56.74±5.51) ng/L vs. (65.86±5.87) ng/L], while the levels of β-EP and 5-HT were higher than those in the control group [(83.45±9.61) ng/L vs. (71.63±8.47) ng/L, (298.86±30.48) ng/L vs. (272.36±28.94) ng/L] (all P<0.05); the levels of COX-2 and iNOS in the acupuncture group were lower than those in the control group [(1.84±0.51) μg/L vs. (2.21±0.63) μg/L, (1.35±0.48) μg/L vs. (3.08±0.77) μg/L] (both P<0.05); the scores for headache severity, accompanying symptoms, monthly attack frequency and duration per attack in the acupuncture group were lower than those in the control group (all P<0.05); the scores for headache and dizziness, irritability and restlessness, insomnia and frequent dreams, tinnitus and vertigo, facial flushing and redness, bitter mouth and dry throat in the acupuncture group were lower than those in the control group (all P<0.05). During the treatment period, no adverse reactions occurred in either group. Conclusion　Liver-sparing and brain-boosting acupuncture combined with zolmitriptan has a better therapeutic effect on patients with migraine with hyperactivity of liver-yang syndrome. It can relieve pain, alleviate the symptoms of migraine, and regulate the levels of vaso-active substance and inflammatory response-related enzymes.

Key words: Migraine, , Liver-sparing and brain-benefiting acupuncture method, , Zolmitriptan, , Acute attacks, , Vaso-active substance, , Inflammatory response-related enzymes

王斌张艳.

疏肝益脑针刺法联合佐米曲普坦治疗肝阳上亢证偏头痛的效果 [J]. 国际医药卫生导报, 2025, 31(13): 2221-2225.

Wang Bin, Zhang Yan.

The effect of liver-sparing and brain-benefiting acupuncture method combined with zolmitriptan in the treatment of migraine with hyperactivity of liver-yang syndrome [J]. International Medicine and Health Guidance News, 2025, 31(13): 2221-2225.

参考文献

[1]郝雨雁,杨琍,肖哲曼.偏头痛发病相关机制的研究[J].中风与神经疾病杂志,2022,39(3):263-266.DOI:10.19845/j.cnki.zfysjjbzz.2022.0067.

[2]刘唯,陆佳洁,郭效宁,等.丛集性头痛发作前驱期口服佐米曲普坦的疗效和安全性[J].徐州医科大学学报,2023,43(3):201-204.DOI:10.3969/j.issn.2096-3882.2023.03.009.

[3]卢恩仕,刘祖发,何丽云.从肝寒理论探讨偏头痛的中医治疗[J].现代中医临床,2024,31(3):69-72.DOI:10.3969/j.issn.2095-6606.2024.03.014.

[4]张力,辛会敏,庄惜兰,等.调神疏肝法针刺治疗偏头痛疗效及对血流动力学的影响[J].中国临床研究,2023,36(11):1703-1707.DOI:10.13429/j.cnki.cjcr.2023.11.022.

[5]中华医学会疼痛学分会头面痛学组,中国医师协会神经内科医师分会疼痛和感觉障碍专委会.中国偏头痛防治指南[J].中国疼痛医学杂志,2016,22(10):721-727.DOI:10.3969/j.issn.1006-9852.2016.10.001.

[6]张伯礼,吴勉华.中医内科学[M].4版.北京:中国中医药出版社,2017:171-180.

[7]孙兵,车晓明.视觉模拟评分法(VAS)[J].中华神经外科杂志,2012,28(6):645.

[8]冯智英,邹静,华驾略,等.国际头痛疾患分类第3版(试用版)--原发性头痛部分解读[J].神经病学与神经康复学杂志,2013,(2):121-140.DOI:10.3969/j.issn.1672-7061.2013.02.010.

[9]郑筱萸.中药新药临床研究指导原则(试行)[M].北京:中国医药科技出版社,2002:108-109.

[10]陆佳洁,赵红如.偏头痛疾病负担研究进展[J].中国现代神经疾病杂志,2022,22(2):69-72.DOI:10.3969/j.issn.1672-6731.2022.02.002.

[11]Ramusino MC, Perini G, Capelli M, et al. Potential contribution of hypertension to evolution of chronic migraine and related mechanisms[J]. J Oral Facial Pain Headache, 2022, 36(3-4):221-228. DOI: 10.11607/ofph.3174.

[12]孙海玲,鲍实,周茜,等.HPLC法测定佐米曲普坦片有关物质及质量评价研究[J].中国药师,2023,26(12):519-526.DOI:10.12173/j.issn.1008-049X.202304118.

[13]南淞华,彭超杰,庞伯通,等.基于CiteSpace的中医药防治偏头痛的知识图谱分析[J].中国医药导报,2023,20(6):115-118,127.DOI:10.20047/j.issn1673-7210.2023.06.26.

[14]胥鑫玉,浦怡婷,吕鹤群,等.针刺治疗偏头痛的机制研究进展[J].针灸临床杂志,2024,40(3):98-102.DOI:10.19917/j.cnki.1005-0779.024062.

[15]焦恩虎,曹伟.针刺联合中西药治疗肝风挟瘀型偏头痛的疗效观察[J].上海针灸杂志,2022,41(7):667-673.DOI:10.13460/j.issn.1005-0957.2022.07.0667.

[16]郑宇琦,孙铭声,刘一,等.基于α7nAChRs的针刺对慢性偏头痛大鼠抗炎作用的研究[J].世界科学技术-中医药现代化,2024,26(4):1050-1058.DOI:10.11842/wst.20230509001.

[17]林淑芳,王嘉驹,陈白,等.针刺太冲穴对肝阳上亢型偏头痛大鼠血清血管活性物质含量的影响[J].世界中医药,2023,18(18):2584-2588.DOI:10.3969/j.issn.1673-7202.2023.18.004.

[18]许晓辉,段智慧,蔡卫卫,等.前庭性偏头痛患者血清5-HT、NO、MMP-9及CGRP的检测及临床意义[J].分子诊断与治疗杂志,2022,14(3):499-502.DOI:10.3969/j.issn.1674-6929.2022.03.035.

[19]包泽岩,胡琼力,庄思典,等.偏头痛病人血清内皮素-1、降钙素基因相关肽、神经降压素水平变化及其与继发缺血性脑卒中的关系[J].安徽医药,2023,27(9):1809-1814.DOI:10.3969/j.issn.1009-6469.2023.09.025.

[20]冯卫星,杜筱筱,贺佳妮,等.艾灸对偏头痛大鼠血清β-EP、SP含量及脑干IL-1β、COX-2蛋白表达的影响[J].中国针灸,2023,43(2):186-190,202.DOI:10.13703/j.0255-2930.20220116-0001.

[21]马建福,张慧,王豆,等.5-羟色胺系统在偏头痛中的作用及中医药干预研究进展[J].中成药,2023,45(8):2656-2661.DOI:10.3969/j.issn.1001-1528.2023.08.034.

[22]潘琪,王运锋,周冀英.选择性5-HT1F受体激动剂治疗偏头痛的疗效与机制[J].中国疼痛医学杂志,2022,28(9):686-691.DOI:10.3969/j.issn.1006-9852.2022.09.007.

[23]崔炜,屈永才.血清COX-2、LPA、VEGF水平在偏头痛患者中检测的临床意义探析[J].齐齐哈尔医学院学报,2021,42(10):843-846.DOI:10.3969/j.issn.1002-1256.2021.10.005.

[24]马杰,廖红娟,张焱,等.血清MMP-9、COX-2、CGRP对偏头痛经导管封堵PFO预后的预测价值[J].分子诊断与治疗杂志,2022,14(6):1052-1055,1059.DOI:10.3969/j.issn.1674-6929.2022.06.038.

[25]汪坤,马鸣,杨艳华,等.基于p38 MAPK/iNOS信号通路探讨加味散偏汤对硝酸甘油诱导的大鼠偏头痛作用机制[J].中国实验方剂学杂志,2023,29(22):64-70.DOI:10.13422/j.cnki.syfjx.20231339.

疏肝益脑针刺法联合佐米曲普坦治疗肝阳上亢证偏头痛的效果

The effect of liver-sparing and brain-benefiting acupuncture method combined with zolmitriptan in the treatment of migraine with hyperactivity of liver-yang syndrome

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 8

编辑推荐

Metrics

[1]	张瑞环杨耀峰郝涛陈钧. 平息内风剂联合针刺治疗偏头痛疗效的meta分析 [J]. 国际医药卫生导报, 2025, 31(4): 552-558.
[2]	郑瑶贾琳楠王智慧曲海丽丁鉴王宝月王平邢文静. β-内啡肽、环氧化酶-2与多巴胺受体D2对右向左分流偏头痛患者焦虑状况的预测价值 [J]. 国际医药卫生导报, 2025, 31(2): 284-288.
[3]	刘雪萍陈如月连梦尧樊晓晨宋秋容. 清金止咳解肌汤辅助治疗老年慢性支气管炎急性发作痰湿蕴肺证的效果 [J]. 国际医药卫生导报, 2024, 30(18): 3107-3111.
[4]	张瑞环郝涛陈钧孙小琳. 针刺联合活血祛瘀剂治疗偏头痛疗效与安全性的meta分析 [J]. 国际医药卫生导报, 2024, 30(13): 2148-2157.
[5]	张烨雯刘忠琴徐华春边淑娟高世婷. 运用脏气法时论指导治疗偏头痛患者的临床观察 [J]. 国际医药卫生导报, 2023, 29(20): 2906-2910.
[6]	严宛鸿薛建军贾瑜王世太. 星状神经节阻滞治疗偏头痛的meta分析 [J]. 国际医药卫生导报, 2023, 29(12): 1629-1635.
[7]	郑玉江, 董艳霞, 何炼图. 经食道超声心动图对中青年偏头痛患者卵圆孔未闭的诊断及介入疗效评估[J]. 国际医药卫生导报, 2022, 28(3): 403-405.
[8]	杨凤玲, 梁林丽, 李婷婷, 郑楚真, 黄雪月. 智慧护理信息系统应用于慢性心力衰竭急性发作患者出院后延续性干预效果评价[J]. 国际医药卫生导报, 2022, 28(1): 82-85.